OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Recent Advancement in the Search of Innovative Antiprotozoal Agents Targeting Trypanothione Metabolism
Francesco Saccoliti, Roberto Di Santo, Roberta Costi
ChemMedChem (2020) Vol. 15, Iss. 24, pp. 2420-2435
Open Access | Times Cited: 22
Francesco Saccoliti, Roberto Di Santo, Roberta Costi
ChemMedChem (2020) Vol. 15, Iss. 24, pp. 2420-2435
Open Access | Times Cited: 22
Showing 22 citing articles:
Antimicrobial Agents Based on Metal Complexes: Present Situation and Future Prospects
Bharti Sharma, Sudeep Shukla, Rohit Rattan, et al.
International Journal of Biomaterials (2022) Vol. 2022, pp. 1-21
Open Access | Times Cited: 48
Bharti Sharma, Sudeep Shukla, Rohit Rattan, et al.
International Journal of Biomaterials (2022) Vol. 2022, pp. 1-21
Open Access | Times Cited: 48
Review on Experimental Treatment Strategies Against Trypanosoma cruzi
Ana Lia Mazzeti, Patrícia Capelari-Oliveira, Maria Terezinha Bahia, et al.
Journal of Experimental Pharmacology (2021) Vol. Volume 13, pp. 409-432
Open Access | Times Cited: 53
Ana Lia Mazzeti, Patrícia Capelari-Oliveira, Maria Terezinha Bahia, et al.
Journal of Experimental Pharmacology (2021) Vol. Volume 13, pp. 409-432
Open Access | Times Cited: 53
Targeting Trypanothione Metabolism in Trypanosomatids
María-Cristina González-Montero, Julia Andrés-Rodríguez, Nerea García-Fernández, et al.
Molecules (2024) Vol. 29, Iss. 10, pp. 2214-2214
Open Access | Times Cited: 8
María-Cristina González-Montero, Julia Andrés-Rodríguez, Nerea García-Fernández, et al.
Molecules (2024) Vol. 29, Iss. 10, pp. 2214-2214
Open Access | Times Cited: 8
Drugs in preclinical and early clinical development for the treatment of Chagas´s disease: the current status
Fernanda Karoline Vieira da Silva Torchelsen, Ana Lia Mazzeti, Vanessa Carla Furtado Mosqueira
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 6, pp. 575-590
Closed Access | Times Cited: 7
Fernanda Karoline Vieira da Silva Torchelsen, Ana Lia Mazzeti, Vanessa Carla Furtado Mosqueira
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 6, pp. 575-590
Closed Access | Times Cited: 7
Metabolic Pathways of Leishmania Parasite: Source of Pertinent Drug Targets and Potent Drug Candidates
Surbhi Jain, Utkarsha Sahu, Awanish Kumar, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1590-1590
Open Access | Times Cited: 25
Surbhi Jain, Utkarsha Sahu, Awanish Kumar, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1590-1590
Open Access | Times Cited: 25
Polyamine Metabolism in Leishmania Parasites: A Promising Therapeutic Target
Nicola S. Carter, Yumena Kawasaki, Surbhi S. Nahata, et al.
Medical Sciences (2022) Vol. 10, Iss. 2, pp. 24-24
Open Access | Times Cited: 18
Nicola S. Carter, Yumena Kawasaki, Surbhi S. Nahata, et al.
Medical Sciences (2022) Vol. 10, Iss. 2, pp. 24-24
Open Access | Times Cited: 18
Drug-like molecules with anti-trypanothione synthetase activity identified by high throughput screening
Diego Benítez, Jaime Franco, Florencia Sardi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 912-929
Open Access | Times Cited: 17
Diego Benítez, Jaime Franco, Florencia Sardi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 912-929
Open Access | Times Cited: 17
32nd Annual GP2A Medicinal Chemistry Conference
Jean‐Jacques Hélesbeux, Florence O. McCarthy, Maria Manuel Silva, et al.
Drugs and Drug Candidates (2025) Vol. 4, Iss. 1, pp. 2-2
Open Access
Jean‐Jacques Hélesbeux, Florence O. McCarthy, Maria Manuel Silva, et al.
Drugs and Drug Candidates (2025) Vol. 4, Iss. 1, pp. 2-2
Open Access
Structural and Kinetic Profiling of Leishmania braziliensis Trypanothione Reductase: A Molecular Model for the Development of Targeted Therapies
Ana Fidelina Gómez Garay, Jorge Alfonso, Áleff Ferreira Francisco, et al.
Biochimie (2025)
Closed Access
Ana Fidelina Gómez Garay, Jorge Alfonso, Áleff Ferreira Francisco, et al.
Biochimie (2025)
Closed Access
Efficient Dimerization Disruption of Leishmania infantum Trypanothione Reductase by Triazole-phenyl-thiazoles
Alejandro Revuelto, Héctor de Lucio, Juan Carlos García-Soriano, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 9, pp. 6137-6160
Open Access | Times Cited: 21
Alejandro Revuelto, Héctor de Lucio, Juan Carlos García-Soriano, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 9, pp. 6137-6160
Open Access | Times Cited: 21
Chemical Strategies towards the Synthesis of Betulinic Acid and Its More Potent Antiprotozoal Analogues
André Barreto Cunha, Ronan Batista, María Ángeles Castro, et al.
Molecules (2021) Vol. 26, Iss. 4, pp. 1081-1081
Open Access | Times Cited: 20
André Barreto Cunha, Ronan Batista, María Ángeles Castro, et al.
Molecules (2021) Vol. 26, Iss. 4, pp. 1081-1081
Open Access | Times Cited: 20
Discovery of novel Leishmania major trypanothione synthetase inhibitors by high-throughput screening
Trong-Nhat Phan, Kyu‐Ho Park, Diego Benítez, et al.
Biochemical and Biophysical Research Communications (2022) Vol. 637, pp. 308-313
Closed Access | Times Cited: 9
Trong-Nhat Phan, Kyu‐Ho Park, Diego Benítez, et al.
Biochemical and Biophysical Research Communications (2022) Vol. 637, pp. 308-313
Closed Access | Times Cited: 9
Systems pharmacology aiding benzimidazole scaffold as potential lead compounds against leishmaniasis for functional therapeutics
Anurag Kumar, Prajakta Nimsarkar, Shailza Singh
Life Sciences (2022) Vol. 308, pp. 120960-120960
Closed Access | Times Cited: 8
Anurag Kumar, Prajakta Nimsarkar, Shailza Singh
Life Sciences (2022) Vol. 308, pp. 120960-120960
Closed Access | Times Cited: 8
Metabolic Pathways of Leishmania Parasite: Source of Pertinent Drug Targets and Potent Drug Candidates
Surbhi Jain, Utkarsha Sahu, Awanish Kumar, et al.
(2022)
Open Access | Times Cited: 6
Surbhi Jain, Utkarsha Sahu, Awanish Kumar, et al.
(2022)
Open Access | Times Cited: 6
Identification of 1,2,3-triazolium salt-based inhibitors of Leishmania infantum trypanothione disulfide reductase with enhanced antileishmanial potency in cellulo and increased selectivity
Héctor de Lucio, Alejandro Revuelto, Alejandra A. Carriles, et al.
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114878-114878
Open Access | Times Cited: 6
Héctor de Lucio, Alejandro Revuelto, Alejandra A. Carriles, et al.
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114878-114878
Open Access | Times Cited: 6
Metabolic control analysis of the transsulfuration pathway and the compensatory role of the cysteine transport in Trypanosoma cruzi
Citlali Vázquez, Rusely Encalada, Javier Belmont-Díaz, et al.
Biosystems (2023) Vol. 234, pp. 105066-105066
Closed Access | Times Cited: 2
Citlali Vázquez, Rusely Encalada, Javier Belmont-Díaz, et al.
Biosystems (2023) Vol. 234, pp. 105066-105066
Closed Access | Times Cited: 2
Synthesis and Antiprotozoal Profile of 3,4,5‐Trisubstituted Isoxazoles
Fernanda A. Rosa, Samara M. de S. Melo, Karlos Eduardo Pianoski, et al.
ChemistryOpen (2021) Vol. 10, Iss. 10, pp. 931-938
Open Access | Times Cited: 4
Fernanda A. Rosa, Samara M. de S. Melo, Karlos Eduardo Pianoski, et al.
ChemistryOpen (2021) Vol. 10, Iss. 10, pp. 931-938
Open Access | Times Cited: 4
RCB-4, a novel cyclic peptide, from Ricinus communis with anti-Trypanosoma cruzi activities
Francianne Galossi-de-Souza, Laís Pessanha de Carvalho, Édesio José Tenório de Melo, et al.
Journal of Molecular Structure (2023) Vol. 1302, pp. 137405-137405
Closed Access | Times Cited: 1
Francianne Galossi-de-Souza, Laís Pessanha de Carvalho, Édesio José Tenório de Melo, et al.
Journal of Molecular Structure (2023) Vol. 1302, pp. 137405-137405
Closed Access | Times Cited: 1
Uncovering the Mechanism of Action of Antiprotozoal Agents: A Survey on Photoaffinity Labeling Strategy
Alessandro Giraudo, Cristiano Bolchi, Marco Pallavicini, et al.
Pharmaceuticals (2024) Vol. 18, Iss. 1, pp. 28-28
Open Access
Alessandro Giraudo, Cristiano Bolchi, Marco Pallavicini, et al.
Pharmaceuticals (2024) Vol. 18, Iss. 1, pp. 28-28
Open Access
2020 Italian Special Anniversary Collection: Celebrating NMMC 2019 and 40 Years of the DCF‐SCI
M. Carini, Marco De Amici
ChemMedChem (2020) Vol. 16, Iss. 2, pp. 303-308
Open Access | Times Cited: 1
M. Carini, Marco De Amici
ChemMedChem (2020) Vol. 16, Iss. 2, pp. 303-308
Open Access | Times Cited: 1
Graphene quantum dots harvest anti-trypanosomatid efficacy by disrupting antioxidant networks centered on trypanothione reductase
Di Zhang, Rui Jü, Limei Li, et al.
Research Square (Research Square) (2023)
Open Access
Di Zhang, Rui Jü, Limei Li, et al.
Research Square (Research Square) (2023)
Open Access
Quantum Dynamics and Bi Metal Force Field Parameterization Yielding Significant Antileishmanial Targets
Naila Zaman, Syed Sikander Azam
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 4, pp. 1371-1385
Closed Access
Naila Zaman, Syed Sikander Azam
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 4, pp. 1371-1385
Closed Access
Small Molecule–Peptide Conjugates as Dimerization Inhibitors of Leishmania infantum Trypanothione Disulfide Reductase
Alejandro Revuelto, Isabel López‐Martín, Héctor de Lucio, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 7, pp. 689-689
Open Access
Alejandro Revuelto, Isabel López‐Martín, Héctor de Lucio, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 7, pp. 689-689
Open Access
